Evaluating the relationship between COVID-19 and ischemic stroke in a consecutive Swiss Stroke Registry analysis

Takeaway

  • Concomitant coronavirus disease 2019 (COVID-19) and ischemic stroke (IS) are fairly rare, but multi-territorial involvement is a distinct feature in COVID-19 patients with IS, and IS/COVID-19 onset is heterogeneous.

Why this matters

  • Current studies evaluating IS in patients with concomitant SARS-CoV-2 infection lack comparison to COVID-19–negative stroke patients or do not evaluate 3-month outcomes.

  • This nationwide study provides evidence that will be useful in identifying and treating patients with COVID-19 at risk for IS, and patients with multi-territorial stroke who may have concomitant COVID-19.